Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Loza, I. Strambu, M. Laviolette, D. Singh, J. M. Fitzgerald, S. Kelsen, A. Eich, A. Ludwig-Sengpiel, G. Chupp, C. Porsbjerg, P. Berger, R. Leigh, J. Kline, M. Dransfield, W. Calhoun, A. Hussaini, P. Chanez, V. S. Susulic, P. E. Silkoff, F. Baribaud (Spring House, Philadelphia, New Haven, Iowa City, Birmingham, Galveston, Baltimore, United States Of America; Bucharest, Romania; Québec, Manchester, United Kingdom; Vancouver, Calgary, Canada; Frankfurt, Lübeck, Germany; Copenhagen, Denmark; Bordeaux, Marseille, France). ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients. Eur Respir J 2013; 42: Suppl. 57, 748

Member's Comments

No comment yet.

Related content which might interest you: A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Asthma phenotypes with rapid decline in lung function Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population Source: Annual Congress 2013 –Is it really asthma? Year: 2013 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Correlation between meteo-climatological factors and asthma exacerbation among children: A prospective study Source: International Congress 2016 – Living with asthma around the globe Year: 2016 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Cluster analysis on longitudinal data of patients with adult-onset asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Predictors of long-term lung function decline in adult-onset asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Work related symptoms of adult patients with asthma: A multicenter, national, questionnaire based study Source: International Congress 2015 – Work, environment and the epidemiology of asthma Year: 2015 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Study of therapeutics effects of montelukast in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 The German COPD cohort COSYCONET: Aims, methods and results of recruitment Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015